Institutional Corruption of Pharmaceuticals and the Drug Safety Myth

Economist Dean Baker on Corrupt Pharmaceuticals, FDA and Government Fines

Following GlaxoSmithKline fined $3 Billion and their plans to share detailed Clinical Trial data online for Researchers, famed economist Dean Baker discusses the corruption, criminality, fines, and the ludicrous profit margins in the pharmaceutical industry with Doctor Sidney Wolf

Read Institutional Corruption of Pharmaceuticals and the Drug Safety Myth, Health Impact News, 4 Dec 2013

  • The Three Levels of Institutional Corruption
  • Do Pharmaceutical Companies Have a Moral Duty to Do No Harm?
  • Conflicts of Interest and Institutional Corruption Within the FDA
  • Can Institutional Integrity Be Restored to Produce Safer Drugs?
  • Proof that “Science-Based” Medicine is Disintegrating

Related posts:

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

2 thoughts on “Institutional Corruption of Pharmaceuticals and the Drug Safety Myth”

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s